Navigation Links
New revelations in epigenetic control shed light on breast cancer
Date:3/5/2008

Epigenetic regulation modifications to the structure of chromatin that influence which genes are expressed in a cell is a key player in embryonic development and cancer formation. Researchers at the European Molecular Biology Laboratory [EMBL] in Heidelberg now gained new insight into one crucial epigenetic mechanism and reveal that it acts much faster than assumed. In this week's issue of Nature they report that estrogen causes rapid epigenetic changes in breast cancer cells. The new findings impact upon our understanding of how cells interpret their DNA and suggest that epigenetic regulation can affect gene expression immediately and long-term.

Epigenetic changes to the structure of chromatin tightly packaged DNA - grant or deny access to the molecular machinery that transcribes DNA and thereby regulate gene expression. One of these mechanisms is DNA methylation, where a small chemical residue called a methyl group is added to strategic bases on the DNA. The methyl group prevents the transcription machinery from docking and thereby shuts down gene expression. For a long time scientists have considered methylation a mechanism of long-term regulation of a gene's activity, because the methylation marks are stable and maintained through cellular replication.

EMBL researchers of the group of Frank Gannon, current director of the Science Foundation Ireland, now found out that methylation marks occur rapidly in breast cancer cells in response to hormones such as estrogen or drug compounds. Estrogen withdrawal or treatment with the established anticancer drug doxorubicin cause the methyl groups to be removed from regulatory regions of specific genes within tens of minutes in human breast cancer cells. The treatment sets off a whole cycle of events: initial demethylation renders silent genes active and subsequent remethylation shuts them down again. This cycle repeats itself every 1.5 hours.

"We observed that unlike assumed for a long time methylation can act on a very short timescale. The results challenge our understanding of epigenetics as a means to regulate gene expression permanently," says Sara Kangaspeska, who carried out the research together with Brenda Stride.

The new insights into the cyclical nature of methylation might shed light on the molecular bases of cancer and development, both processes involving epigenetic mechanisms.

"In particular breast cancer is affected by estrogen signalling and changes in epigenetic control," says George Reid, co-senior author of the study. "Our next step will be to find small molecules that target the cyclical methylation processes to elucidate their precise role."


'/>"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-139-7452
European Molecular Biology Laboratory
Source:Eurekalert

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
3. New Asthma Guidelines Stress Disease Control
4. UI nursing researcher to study post-operative pain control
5. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
6. Hispanics hypertension better controlled with equal access to care
7. Detroit Metro Tower Air Traffic Controllers File Lawsuit Alleging Improper Mold Removal and Health Effects
8. Maternal depression and controlling behavior associated with increased stress response in infants
9. New Website Helps Women Be Fit, Sexy and in Control!
10. Controlling for size may also prevent cancer
11. Cancer control in Europe works; now it is time to extend it to poorer countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision ... executive staff with the addition of industry sales leader, Thomas (Tom) Slott, as ... the national distribution and sales network, direct the efforts of the surgical sales ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
Breaking Medicine Technology: